GSTM2 and colorectal carcinoma: A robust diagnostic panel (S100A11/CA4/PDCD4/GSTM2/SORD), validated through LASSO, SVM, and random forest algorithms, demonstrated high accuracy (AUC=0.965) and clinical utility for early CRC detection.